Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amesite Inc. - Common Stock (NQ:AMST)

3.369 +0.029 (+0.87%)
Streaming Delayed Price Updated: 10:41 AM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amesite Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Amesite Inc. (NASDAQ: AMST) Near the Top of Equities by Percentage Gain on 4/6
Via Investor Brand Network
Topics Artificial Intelligence
10 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
NAFEO-Amesite HBCU Alliance Welcomes 12 New Member Universities
Amesite Inc. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why Amesite Stock Is Trading Sharply Lower
Amesite Inc (NASDAQ: AMST) shares are trading lower by 29.59% to $2.91 going into the close of Wednesday's session after the company effected a 1-for-12 reverse stock split. What Else? 
Via Benzinga
Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43. 
Via Benzinga
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Launches V6 Platform Featuring GPT-4 Powered Functionality
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Announces Expansion of Member Universities to NAFEO Alliance
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Eyes Opportunity as a Frontrunner for Integrating ChatGPT
Via Investor Brand Network
Topics Artificial Intelligence
From Releasing A Public Course On Using ChatGPT To Leveraging The AI To Improve Company Efficiency — Amesite (NASDAQ: AMST) Looks Ahead Of The Curve For Integrating ChatGPT
By David Willey, Benzinga 
Via TheNewswire.com
Topics Artificial Intelligence
From Releasing A Public Course On Using ChatGPT To Leveraging The AI To Improve Company Efficiency — Amesite (NASDAQ: AMST) Looks Ahead Of The Curve For Integrating ChatGPT
From Releasing A Public Course On Using ChatGPT To Leveraging The AI To Improve Company Efficiency — Amesite (NASDAQ: AMST) Looks Ahead Of The Curve For Integrating ChatGPT 
Via News Direct
Topics Artificial Intelligence
From Releasing A Public Course On Using ChatGPT To Leveraging The AI To Improve Company Efficiency — Amesite (NASDAQ: AMST) Looks Ahead Of The Curve For Integrating ChatGPT
Click here to read the latest report on Amesite Inc.  
Via Benzinga
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Delivering FERPA and COPPA-Compliant Learning Programs
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Releases Statement Regarding No Accounts with, Relationship to Silicon Valley Bank
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Regains Compliance with NASDAQ Minimum Bid Price, Other Listing Requirements
Via Investor Brand Network
Topics Artificial Intelligence
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) CEO Expands Company Owned Stock with Series of Recent Purchases
Via Investor Brand Network
Topics Artificial Intelligence
Insider Buying: AI Firm Amesite (NASDAQ: AMST) CEO Ann Marie Sastry Picks Up Company Stock Multiple Times, Has Never Sold Stock To Date
By David Willey, Benzinga 
Via TheNewswire.com
Topics Artificial Intelligence
Insider Buying: AI Firm Amesite (NASDAQ: AMST) CEO Ann Marie Sastry Picks Up Company Stock Multiple Times, Has Never Sold Stock To Date
Insider Buying: AI Firm Amesite (NASDAQ: AMST) CEO Ann Marie Sastry Picks Up Company Stock Multiple Times, Has Never Sold Stock To Date 
Via News Direct
Topics Artificial Intelligence
Insider Buying: AI Firm Amesite (NASDAQ: AMST) CEO Ann Marie Sastry Picks Up Company Stock Multiple Times, Has Never Sold Stock To Date
Read the latest report on Amesite Inc. here! 
Via Benzinga
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Partners with Benedict College to Launch Technology Upskilling Pilot Program
Via Investor Brand Network
Topics Artificial Intelligence
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) to Provide Video Update for Shareholders
Via Investor Brand Network
Topics Artificial Intelligence
Good Times Restaurants And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers Cingulate Inc (NASDAQ: CING) rose 85.7% to $2.08 in pre-market trading after the company disclosed top-line results from Fed/Fast study of lead asset CTx-1301 for ADHD. 
Via Benzinga
Amesite: Changing The Face Of Education Through AI
Dr. Ann Marie Sastry, CEO of Amesite Inc (NASDAQ: AMST), was recently a guest on Benzinga’s All Access. 
Via Benzinga
Dow Rises 50 Points; Quoin Pharmaceuticals Shares Plunge
U.S. stocks traded slightly higher toward the end of trading following the release of Fed minutes. The Dow traded up 0.15% to 33,180.87 while the NASDAQ rose 0.49% to 11,548.73. The S&P 500 also rose,... 
Via Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.